SG11202010683PA - Use of vibegron to treat pain associated with irritable bowel syndrome - Google Patents
Use of vibegron to treat pain associated with irritable bowel syndromeInfo
- Publication number
- SG11202010683PA SG11202010683PA SG11202010683PA SG11202010683PA SG11202010683PA SG 11202010683P A SG11202010683P A SG 11202010683PA SG 11202010683P A SG11202010683P A SG 11202010683PA SG 11202010683P A SG11202010683P A SG 11202010683PA SG 11202010683P A SG11202010683P A SG 11202010683PA
- Authority
- SG
- Singapore
- Prior art keywords
- vibegron
- bowel syndrome
- irritable bowel
- pain associated
- treat pain
- Prior art date
Links
Classifications
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/33—Heterocyclic compounds
- A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
- A61K31/495—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with two or more nitrogen atoms as the only ring heteroatoms, e.g. piperazine or tetrazines
- A61K31/505—Pyrimidines; Hydrogenated pyrimidines, e.g. trimethoprim
- A61K31/519—Pyrimidines; Hydrogenated pyrimidines, e.g. trimethoprim ortho- or peri-condensed with heterocyclic rings
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K45/00—Medicinal preparations containing active ingredients not provided for in groups A61K31/00 - A61K41/00
- A61K45/06—Mixtures of active ingredients without chemical characterisation, e.g. antiphlogistics and cardiaca
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K9/00—Medicinal preparations characterised by special physical form
- A61K9/0012—Galenical forms characterised by the site of application
- A61K9/0053—Mouth and digestive tract, i.e. intraoral and peroral administration
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P1/00—Drugs for disorders of the alimentary tract or the digestive system
Landscapes
- Health & Medical Sciences (AREA)
- Pharmacology & Pharmacy (AREA)
- Veterinary Medicine (AREA)
- Chemical & Material Sciences (AREA)
- Public Health (AREA)
- General Health & Medical Sciences (AREA)
- Medicinal Chemistry (AREA)
- Animal Behavior & Ethology (AREA)
- Life Sciences & Earth Sciences (AREA)
- Epidemiology (AREA)
- Organic Chemistry (AREA)
- Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
- General Chemical & Material Sciences (AREA)
- Chemical Kinetics & Catalysis (AREA)
- Bioinformatics & Cheminformatics (AREA)
- Engineering & Computer Science (AREA)
- Nutrition Science (AREA)
- Physiology (AREA)
- Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
- Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
Applications Claiming Priority (3)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| US201862675747P | 2018-05-23 | 2018-05-23 | |
| US201862775751P | 2018-12-05 | 2018-12-05 | |
| PCT/IB2019/054304 WO2019224788A1 (fr) | 2018-05-23 | 2019-05-23 | Utilisation de vibegron pour traiter la douleur associée au syndrome du côlon irritable |
Publications (1)
| Publication Number | Publication Date |
|---|---|
| SG11202010683PA true SG11202010683PA (en) | 2020-12-30 |
Family
ID=67226310
Family Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| SG11202010683PA SG11202010683PA (en) | 2018-05-23 | 2019-05-23 | Use of vibegron to treat pain associated with irritable bowel syndrome |
Country Status (7)
| Country | Link |
|---|---|
| US (1) | US20210196720A1 (fr) |
| AU (1) | AU2019273837A1 (fr) |
| CA (1) | CA3098536A1 (fr) |
| IL (1) | IL278876A (fr) |
| SG (1) | SG11202010683PA (fr) |
| TW (1) | TW202015692A (fr) |
| WO (1) | WO2019224788A1 (fr) |
Family Cites Families (4)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| PE20091825A1 (es) | 2008-04-04 | 2009-12-04 | Merck & Co Inc | Hidroximetil pirrolidinas como agonistas del receptor adrenergico beta 3 |
| WO2013062881A1 (fr) | 2011-10-27 | 2013-05-02 | Merck Sharp & Dohme Corp. | Procédé de préparation d'agonistes bêta 3 et d'intermédiaires associés |
| US9809536B2 (en) | 2011-10-27 | 2017-11-07 | Merck Sharp & Dohme Corp. | Process for making beta 3 agonists and intermediates |
| PT2968269T (pt) | 2013-03-15 | 2019-10-08 | Merck Sharp & Dohme | Processo para preparação de beta 3 agonistas e intermediários |
-
2019
- 2019-05-23 CA CA3098536A patent/CA3098536A1/fr not_active Abandoned
- 2019-05-23 WO PCT/IB2019/054304 patent/WO2019224788A1/fr active Application Filing
- 2019-05-23 TW TW108117911A patent/TW202015692A/zh unknown
- 2019-05-23 AU AU2019273837A patent/AU2019273837A1/en not_active Abandoned
- 2019-05-23 SG SG11202010683PA patent/SG11202010683PA/en unknown
- 2019-05-23 US US17/057,554 patent/US20210196720A1/en not_active Abandoned
-
2020
- 2020-11-22 IL IL278876A patent/IL278876A/en unknown
Also Published As
| Publication number | Publication date |
|---|---|
| US20210196720A1 (en) | 2021-07-01 |
| TW202015692A (zh) | 2020-05-01 |
| WO2019224788A1 (fr) | 2019-11-28 |
| IL278876A (en) | 2021-01-31 |
| CA3098536A1 (fr) | 2019-11-28 |
| AU2019273837A1 (en) | 2020-11-19 |
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| ZA201802643B (en) | Methods of treating pain or fever using pharmaceutically active acetaminophen dimers linked through phenolic hydroxyl groups | |
| GB201804514D0 (en) | Treatment of pyroptosis | |
| IL272937A (en) | Preparations and methods for the treatment of diseases involving fibrosis | |
| HK1249865B (zh) | 疼痛的治療 | |
| ZA202003785B (en) | Use of coriobacteriia to promote gut health | |
| IL282311A (en) | Raboxetine for the treatment of narcolepsy | |
| IL271164A (en) | Use of vibragron to treat overactive bladder | |
| ZA201907401B (en) | Treatment of adipocytes | |
| GB201801170D0 (en) | Use of polyoxometalate mediators | |
| ZA201903795B (en) | Treatment of water | |
| GB201804515D0 (en) | Treatment of necroptosis | |
| SG11202103319SA (en) | Treatment of pain with polysulfated polysaccharides | |
| IL280663B1 (en) | Thermochemical treatment of cellulosic materials | |
| IL264467B (en) | Compounds and methods for the treatment of irritable bowel syndrome | |
| IL278876A (en) | Use of vibegron to treat pain associated with irritable bowel syndrome | |
| IL282869A (en) | Use of tibozenib to treat patients with resistant cancer | |
| PT3582764T (pt) | Tratamento da perturbação de uso de álcool | |
| EP3979992A4 (fr) | Traitement de la douleur abdominale associée au syndrome du côlon irritable à diarrhée prédominante | |
| ZA201904327B (en) | Treatment of skin conditions | |
| SG11202007642RA (en) | Treatment of disorders with tasimelteon | |
| HK1216151A1 (zh) | 匹多莫德治療腸易激綜合症的用途 | |
| GB201821093D0 (en) | Treatment of hydrocarbons | |
| PL3638223T3 (pl) | Bromheksyna w leczeniu bólu | |
| GB201801249D0 (en) | Methods of treatment | |
| GB201523001D0 (en) | The combination of traditional chinese medicines to treat gastroptosis |